<?xml version="1.0" encoding="UTF-8"?>
<p>Recently, there has been a great interest regarding the role of dietary antioxidants in neurodegenerative diseases, such as Alzheimerâ€™s disease (AD) [
 <xref rid="B12-plants-10-00153" ref-type="bibr">12</xref>]. Although pomegranate is rich in antioxidant polyphenols and oxidative stress may play a key role in neurodegenerative disease, few in vivo and in vitro studies analyzed its activity as a potential inhibitor of acetylcholinesterase (AChE) [
 <xref rid="B12-plants-10-00153" ref-type="bibr">12</xref>,
 <xref rid="B13-plants-10-00153" ref-type="bibr">13</xref>,
 <xref rid="B14-plants-10-00153" ref-type="bibr">14</xref>]. In AD transgenic mice, a dietary supplementation with 4% of pomegranate attenuated the oxidative damage and reduced the activity of AChE, restoring its normal levels [
 <xref rid="B12-plants-10-00153" ref-type="bibr">12</xref>]. Furthermore, an ethanol extract of pomegranate leaves or peels showed good AChE inhibition activities [
 <xref rid="B13-plants-10-00153" ref-type="bibr">13</xref>,
 <xref rid="B14-plants-10-00153" ref-type="bibr">14</xref>].
</p>
